Adelanta tu networking para South Summit 2024 revisando nuestro marketplace, donde encontrarás los perfiles de todas las Startups, Colaboradores, Aceleradoras e Instituciones que participarán en el evento.
Busco una relación con una Trabajando en Que puedan colaborar con mi proyecto via
Chronic pain affects around 1.5 billion people worldwide. Conventional treatment for chronic pain consists mostly of opioid narcotics. However, opioids have failed us as the US is currently undergoing an opioid epidemic. At Navega, we have developed a patented, non-permanent therapy to target pain that is non-addictive, highly specific, and long-term lasting. So how does this work? We were inspired by nature: there are humans that have a mutation in their genome that feel no pain whatsoever. We have imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way. In our proof-of-concept, we demonstrated that the mice that received our therapy had increased pain tolerance and lower pain levels.
Si tienes una propuesta sobre algunas de las siguientes áreas, estaremos encantados de analizarlas:
